Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults

Rosa Costa, Felipe Bueno, Eliseo Albert, Ignacio Torres, Silvia Carbonell-Sahuquillo, Ana Barrés-Fernández, David Sánchez, Carmelo Padrón, Javier Colomina, María Isabel Lázaro Carreño, José Rafael Bretón-Martínez, Cecilia Martínez-Costa, David Navarro, Rosa Costa, Felipe Bueno, Eliseo Albert, Ignacio Torres, Silvia Carbonell-Sahuquillo, Ana Barrés-Fernández, David Sánchez, Carmelo Padrón, Javier Colomina, María Isabel Lázaro Carreño, José Rafael Bretón-Martínez, Cecilia Martínez-Costa, David Navarro

Abstract

Objectives: Studies comparing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA load in the upper respiratory tract (URT) between children and adults-who either presented with coronavirus disease 2019 (COVID-19) or were asymptomatic-have yielded inconsistent results. Here, we conducted a retrospective, single-centre study to address this issue.

Patients and methods: Included were 1184 consecutive subjects (256 children and 928 adults) testing positive for SARS-CoV-2 RNA in nasopharyngeal exudates (NPs); of these, 424 (121 children and 303 adults) had COVID-19 and 760 (135 children and 625 adults) were asymptomatic close contacts of COVID-19 patients. SARS-CoV-2 RNA testing was carried out using the TaqPath COVID-19 Combo Kit (Thermo Fisher Scientific, MS, USA). The AMPLIRUN® TOTAL SARS-CoV-2 RNA Control (Vircell SA, Granada, Spain) was used for estimating SARS-CoV-2 RNA loads (in copies/mL). SARS-CoV-2 RNA loads at the time of laboratory diagnosis (single specimen/patient) were used for comparison purposes.

Results: Median initial SARS-CoV-2 RNA load was lower (p 0.094) in children (6.98 log10 copies/mL, range 3.0-11.7) than in adults (7.14 log10 copies/mL, range 2.2-13.4) with COVID-19. As for asymptomatic individuals, median SARS-CoV-2 RNA load was comparable (p 0.97) in children (6.20 log10 copies/mL, range 1.8-11.6) and adults (6.48 log10 copies/mL, range 1.9-11.8). Children with COVID-19 symptoms displayed SARS-CoV-2 RNA loads (6.98 log10 copies/mL, range 3.0-11.7) comparable to those of their asymptomatic counterparts (6.20 log10 copies/mL, range 1.8-11.6) (p 0.61). Meanwhile in adults, median SARS-CoV-2 RNA load was significantly higher in symptomatic (7.14 log10 copies/mL, range 2.2-13.4) than in asymptomatic subjects (6.48 log10 copies/mL, range 1.9-11.8) (p < 0.001). Overall, the observed URT SARS-CoV-2 RNA clearance rate was faster in children than in adults.

Conclusions: Based on viral load data at the time of diagnosis, our results suggest that SARS-CoV-2-infected children, with or without COVID-19, may display NP viral loads of comparable magnitude to those found in their adult counterparts. However, children may have shorter viral shedding than adults.

Keywords: Adults; COVID-19; Children; SARS-CoV-2 RNA; Upper respiratory tract; Viral load.

Copyright © 2021 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Figures

Fig. 1
Fig. 1
Overall initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA loads in nasopharyngeal specimens from children and adults with coronavirus disease 2019 (COVID-19). Medians are indicated by midlines; the top and bottom edges of boxes represent the interquartile range (IQR). Whiskers indicate the upper and lower values. The number of patients in each group as well as p values for comparisons between groups (median SARS-CoV-2 RNA levels) are shown.
Fig. 2
Fig. 2
Initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA loads in nasopharyngeal specimens from children and adults with coronavirus disease 2019 (COVID-19) according to the time of sampling after symptom onset. Medians are indicated by midlines; the top and bottom edges of boxes represent the interquartile range (IQR). Whiskers indicate the upper and lower values. The number of patients in each group as well as p values for comparisons between groups (median SARS-CoV-2 RNA levels) are shown.
Fig. 3
Fig. 3
Correlation between initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA load in nasopharyngeal specimens from (A) adults and (B) children with coronavirus disease 2019 (COVID-19), and from (C) asymptomatic adults and (D) children and age of participants.
Fig. 4
Fig. 4
Overall initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA loads in nasopharyngeal specimens from asymptomatic children and adults with coronavirus disease 2019 (COVID-19). Medians are indicated by midlines; the top and bottom edges of boxes represent the interquartile range (IQR). Whiskers indicate the upper and lower values. The number of patients in each group as well as p values for comparisons between groups (median SARS-CoV-2 RNA levels) are shown.
Fig. 5
Fig. 5
Comparison of initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA loads in nasopharyngeal specimens from (A) children and (B) adults either asymptomatic or presenting with coronavirus disease 2019 (COVID-19). Medians are indicated by midlines; the top and bottom edges of boxes represent the interquartile range (IQR). Whiskers indicate the upper and lower values. The number of patients in each group as well as p values for comparisons between groups (median SARS-CoV-2 RNA levels) are shown.
figs1
figs1
figs2
figs2
figs3
figs3

References

    1. Viner R.M., Mytton O.T., Bonell C., Melendez-Torres G.J., Ward J., Hudson L., et al. Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: a systematic review and meta-analysis. JAMA Pediatr. 2021;175:143–156.
    1. Wölfel R., Corman V.M., Guggemos W., Seilmaier M., Zange S., Müller M.A. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465–469.
    1. Huang C.G., Lee K.M., Hsiao M.J., Yang S.L., Huang P.N., Gong Y.N. Culture-based virus isolation to evaluate potential infectivity of clinical specimens tested for COVID-19. J Clin Microbiol. 2020;58
    1. Bullard J., Dust K., Funk D., Strong J.E., Alexander D., Garnett L. Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples. Clin Infect Dis. 2020:ciaa638.
    1. L’Huillier A.G., Torriani G., Pigny F., Kaiser L., Eckerle I. Culture-competent SARS-CoV-2 in nasopharynx of symptomatic neonates, children, and adolescents. Emerg Infect Dis. 2020;26:26.
    1. Marks M., Millat-Martinez P., Ouchi D., Roberts C.H., Alemany A., Corbacho-Monné M., et al. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study. Lancet Infect Dis. 2021;21:629–636.
    1. Colson P., Tissot-Dupont H., Morand A., Boschi C., Ninove L., Esteves-Vieira V., et al. Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults. Eur J Clin Microbiol Infect Dis. 2020;39:1983–1987.
    1. Jones T.C., Mühlemann B., Veith T., Biele G., Zuchowski M., Hoffmann J., et al. An analysis of SARS-CoV-2 viral load by patient age. medRxiv. 2020;2020:20125484. 06.08.20125484.
    1. Heald-Sargent T., Muller W.J., Zheng X., Rippe J., Patel A.B., Kociolek L.K. Age-related differences in nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) levels in patients with mild to moderate coronavirus disease 2019 (COVID-19) JAMA Pediatr. 2020;174:902.
    1. L’Huillier A.G., Baggio S., Eckerle I. Viral loads of SARS-CoV-2 in young children. JAMA Pediatr. 2021;175:529–530.
    1. Baggio S., L’Huillier A.G., Yerly S., Bellon M., Wagner N., Rohr M. SARS-CoV-2 viral load in the upper respiratory tract of children and adults with early acute COVID-19. Clin Infect Dis. 2020:ciaa1157.
    1. Kociolek L.K., Muller W.J., Yee R., Dien Bard J., Brown C.A., Revell P.A., et al. Comparison of upper respiratory viral load distributions in asymptomatic and symptomatic children diagnosed with SARS-CoV-2 infection in pediatric hospital testing programs. J Clin Microbiol. 2020;59
    1. Han M.S., Choi E.H., Chang S.H., Jin B.L., Lee E.J., Kim B.N., et al. Clinical characteristics and viral RNA detection in children with coronavirus disease 2019 in the Republic of Korea. JAMA Pediatr. 2021;175:73–80.
    1. Kam K.Q., Thoon K.C., Maiwald M., Chong C.Y., Soong H.Y., Loo L.H., et al. SARS-CoV-2 viral RNA load dynamics in the nasopharynx of infected children. Epidemiol Infect. 2021;149:e18A.
    1. Estrategia de detección precoz, vigilancia y control de COVID-19. November 11 2020.
    1. Albert E., Torres I., Bueno F., Huntley D., Molla E., Fernández-Fuentes M.Á., et al. Field evaluation of a rapid antigen test (Panbio COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres. Clin Microbiol Infect. 2021;27 472.e7–472.
    1. Torres I., Poujois S., Albert E., Colomina J., Navarro D. Evaluation of a rapid antigen test (Panbio COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients. Clin Microbiol Infect. 2021;S1198-743X:30782–30785.
    1. Albert E., Ferrer B., Torres I., Serrano A., Alcaraz M.J., Buesa J., et al. Amplification of human beta-glucuronidase gene for appraising the accuracy of negative SARS-CoV-2 RT-PCR results in upper respiratory tract specimens. J Med Virol. 2021;93:48–50.
    1. Cevik M., Tate M., Lloyd O., Maraolo A.E., Schafers J., Ho A. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe. 2021;2:e13–e22.
    1. Bi Q., Wu Y., Mei S., Ye C., Zou X., Zhang Z., et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020;20:911–919.
    1. Kelvin A.A., Halperin S. COVID-19 in children: the link in the transmission chain. Lancet Infect Dis. 2020;20:633–634.
    1. Jordan I., de Sevilla M.F., Fumado V., Bassat Q., Bonet-Carne E., Fortuny C., et al. Transmission of SARS-CoV-2 infection among children in summer schools applying stringent control measures in Barcelona, Spain. Clin Infect Dis. 2021:ciab227.
    1. Munro A.P.S., Faust S.N. Children are not COVID-19 super spreaders: time to go back to school. Arch Dis Child. 2020;105:618–619.
    1. Riediker M., Morawska L. Low exhaled droplet formation may explain why children are poor SARS-CoV-2 transmitters. Aerosol Air Qual Res. 2020;20:1513–1515.
    1. Lyngse F.P., Mølbak K., Frank K.T., Nielsen C., Skov R.L., Kirkeby V.C. Association between SARS-CoV-2 transmission risk, viral load, and age: a nationwide study in Danish households. medRxiv. 2021 doi: 10.1101/2021.02.28.21252608.
    1. Zou L., Ruan F., Huang M., Liang L., Huang H., Hong Z., et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382:1177–1179.
    1. Huff H.V., Singh A. Asymptomatic transmission during the COVID-19 pandemic and implications for public health strategies. Clin Infect Dis. 2020:ciaa654.
    1. Johansson M.A., Quandelacy T.M., Kada S., Prasad P.V., Steele M., Brooks J.T., et al. SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Netw Open. 2021;4
    1. Qiu X., Nergiz A.I., Maraolo A.E., Bogoch, Low N., Cevik M. The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review. Clin Microbiol Infect. 2021;27:511–519.
    1. Buitrago-Garcia D., Egli-Gany D., Counotte M.J., Hossmann S., Imeri H., Ipekci A.M., et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med. 2020;17
    1. Li F., Li Y.Y., Liu M.J., Fang L.Q., Dean N.E., Wong G.W.K., et al. Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study. Lancet Infect Dis. 2021;21:617–628.
    1. Wu P., Liu F., Chang Z., Lin Y., Ren M., Zheng C., et al. Assessing asymptomatic, pre-symptomatic and symptomatic transmission risk of SARS-CoV-2. Clin Infect Dis. 2021:ciab271.
    1. Lee S., Kim T., Lee E., Lee C., Kim H., Rhee H., et al. Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with SARS-CoV-2 infection in a community treatment center in the Republic of Korea. JAMA Intern Med. 2020;180:1–6.
    1. Ra S.H., Lim J.S., Kim G.U., Kim M.J., Jung J., Kim S.H. Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection. Thorax. 2021;76:61–63.
    1. Hurst J.H., Heston S.M., Chambers H.N., Cunningham H.M., Price M.J., Suarez L., et al. SARS-CoV-2 infections among children in the biospecimens from respiratory virus-exposed kids (BRAVE kids) study. Clin Infect Dis. 2020:ciaa1693.
    1. Albert E., Bracho M.A., Serrano A., Ferrer B., González-Candelas F., Navarro D. Assessing the potential association between SARS-CoV-2 RNA load in the respiratory tract and COVID-19 mortality. J Med Virol. 2021;93:1862–1864.

Source: PubMed

3
Subscribe